ANI Pharmaceuticals (ANIP) PT Lowered to $60 at Roth Capital
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $71.99 -1.72%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Roth Capital analyst Scott Henry lowered his price target on Neutral-rated ANI Pharmaceuticals (NASDAQ: ANIP) to $60.00 (from $78.00) to reflect a more conservative environment and multiple contraction in the generic sector.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $52.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
